Diabetes medications may help reduce asthma attacks

Publicly released:
International
Image by Jake Parkinson from Pixabay
Image by Jake Parkinson from Pixabay

The common diabetes drug, metformin, may reduce asthma attacks in people with type 2 diabetes, according to international research which analysed data from 12,702 people with both asthma and type 2 diabetes in the UK. According to the researchers, using metformin lowered the risk of asthma attacks by 30%. They also found that the addition of another group of diabetes drugs, the glucagon-like peptide-1 receptor agonists (GLP-1RA), was associated with a further 40% lowered risk.  The authors suggest the potential for repurposing diabetic drugs to much-needed alternative treatments for asthma. They say that further research, including randomized clinical trials, is needed to confirm their effect and the mechanism of action in asthma.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research JAMA, Web page URL will go live after the embargo lifts
Journal/
conference:
JAMA Internal Medicine
Research:Paper
Organisation/s: Imperial College London, England
Funder: This research was supported by Asthma + Lung UK (WADR22\100003).
Media Contact/s
Contact details are only visible to registered journalists.